Showing results (71-80 of 235) with videos related to
Sort By:
Pageof 24
Genes and Immunity|March 15, 2018
Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2)Sarah E Kleinstein, Patrick R Shea, Andrew S Allen, et al.Archives of Virology|April 30, 2008
Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2William J Muller, Nural N Orgun, Lichun Dong, et al.Clinical and Vaccine Immunology : CVI|March 21, 2008
Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjectsDavid M Koelle, Amalia Magaret, Christopher L McClurkan, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cellsLidija Bosnjak, Monica Miranda-Saksena, David M Koelle, et al.American Journal of Respiratory and Critical Care Medicine|February 19, 2016
Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination SurveyBijan J Ghassemieh, Engi F Attia, David M Koelle, et al.The Journal of Clinical Investigation|April 29, 1998
Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytesD M Koelle, C M Posavad, G R Barnum, et al.Nature Communications|March 8, 2025
Longitudinal single cell profiling of epitope specific memory CD4+ T cell responses to recombinant zoster vaccineXiaomin Wen, Alex K Hu, Scott R Presnell, et al.Plos Pathogens|September 3, 2024
A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversionKening Wang, Tristan Jordan, Kennichi Dowdell, et al.The Journal of Clinical Investigation|October 3, 2023
Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunityKerry J Laing, Emily S Ford, Michael J Johnson, et al.Nature Reviews. Microbiology|February 24, 2026
Varicella zoster virus and the central nervous systemBenson Ogunjimi, Charlotte Warren-Gash, Werner J D Ouwendijk, et al.Pageof 24